Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Insilico Medicine
Biotech
Lilly embraces AI biotech Insilico again, inking $2.75B collab
Eli Lilly and AI-powered clinical-stage biotech Insilico Medicine have announced a back-loaded, $2.75 billion biobucks drug discovery collaboration.
Will Maddox
Mar 29, 2026 8:00pm
Sanofi's stunning CEO switch—Chutes & Ladders
Feb 13, 2026 8:30am
Qilu inks $120M, AI-enabled cardiometabolic pact with Insilico
Jan 27, 2026 5:20am
Insilico agrees to $66M deal to split rights for NLRP3 inhibitor
Jan 21, 2026 7:05am
Insilico pens potential $888M cancer R&D pact with Servier
Jan 4, 2026 7:30pm
Insilico Medicine aims to generate nearly $300M in Hong Kong IPO
Dec 18, 2025 11:17am
